Internal Medicine

The management of clear-cell renal-cell carcinoma (ccRCC) is undergoing a rapid evolution. Specifically, the combination of … Does Belzutifan Plus Pembrolizumab Stop Kidney Cancer?Read more

Medical professionals in India frequently search for cost-effective disease-modifying therapies for multiple sclerosis. Recently, the landmark … Off-Label Rituximab Matches Ocrelizumab in MSRead more

Clinical oncologists constantly search for better ways to prevent tumor recurrence in high-risk patients. Recently, a … Will This Dual Therapy Prevent Kidney Cancer Recurrence?Read more

Choosing between rituximab versus ocrelizumab remains a critical clinical decision for neurologists managing relapsing multiple sclerosis … Is Rituximab as Effective as Ocrelizumab in Relapsing MS?Read more

Developing robust clinical practice guidelines requires systematic collaboration with diverse interest-holders, including patients, clinicians, and policymakers. … How the RIGHT-MuSE Checklist Transforms Guideline QualityRead more

Managing type 2 diabetes mellitus (T2DM) effectively remains a primary challenge for healthcare providers globally. However, … Is Biweekly Bofanglutide Better Than Weekly Semaglutide?Read more

Introduction Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have transformed the treatment of obesity and type 2 diabetes. … Generating Reliable Real-World Evidence for GLP-1 DrugsRead more

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are transforming diabetes and obesity management worldwide. Consequently, clinical interest in … How Real-World Evidence is Reshaping GLP-1 TherapyRead more

Many patients hesitate to receive their COVID-19 and influenza vaccines on the same day because of … Is It Safe to Get Your COVID and Flu Shots Together?Read more

Managing long-term musculoskeletal discomfort remains a significant challenge for healthcare providers globally. Furthermore, implementing CBT for … Is Self-Directed CBT Better for Managing Chronic Pain?Read more